Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426
Publisher: BioMed Central

Publications (51)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy (2024) Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, et al. Journal article Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases (2024) Oltmanns F, Vieira Antao AI, Irrgang P, Viherlehto V, Jörg L, Schmidt A, Wagner J, et al. Journal article TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy (2024) Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, et al. Journal article Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG (2023) Haist M, Stege H, Rogall F, Tan Y, von Wasielewski I, Klespe KC, Meier F, et al. Journal article Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma (2023) Maerkl F, Benmebarek MR, Keyl J, Cadilha BL, Geiger M, Karches C, Obeck H, et al. Journal article Accumulation of T-cell-suppressive PD-L1 high extracellular vesicles is associated with GvHD and might impact GvL efficacy (2023) Baur R, Karl F, Böttcher-Loschinski R, Stoll A, Völkl S, Gießl A, Flamann C, et al. Journal article IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY (2022) Zhou JG, Gaipl U, Ma H, Wang H Conference contribution Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors (2022) Borchmann S, Selenz C, Lohmann M, Ludwig H, Gassa A, Braegelmann J, Lohneis P, et al. Journal article Automated, scaled, transposon-based production of CAR T cells (2022) Lock D, Monjezi R, Brandes C, Bates S, Lennartz S, Teppert K, Gehrke L, et al. Journal article BISPECIFIC ANTIBODIES ENABLE SYNTHETIC AGONISTIC RECEPTOR T CELL THERAPY IN MELANOMA (2022) Benmebarek M, Maerkl F, Keyl J, Cadilha B, Geiger M, Karches C, Obeck H, et al. Conference contribution